In addition, ET antagonism plays an important role in inhibiting the tumor-promoting properties of fibroblasts depending on tumor type, as shown in colorectal cancer, where selective antagonism of ETAR prevents ET1-stimulated proliferation of fibroblasts, while antagonism of ETBR inhibits ET1-mediated contraction [81]. Here, EDNRA is linked to neoplasm.